Literature DB >> 12083434

The geographical and temporal evolution of sexually transmitted disease epidemics.

G P Garnett1.   

Abstract

In developing appropriate interventions to control sexually transmitted infections (STIs) it is important to understand the distribution of infections, and how this distribution is influenced by the dynamic nature of epidemics. The epidemiology of STIs has been described as a series of phases, which loosely positions a population within the history of an epidemic. The relation between a mathematical theory describing STI epidemiology and the taxonomy of "phases" is explored in this review of the transmission dynamics of STIs. The likelihood of spread and persistence of infection depends upon the basic reproductive number, whereas the endemic prevalence of infection depends upon the way in which heterogeneity in risk focuses the density dependent constraints limiting the spread of infection. All interventions aimed at reducing the prevalence and incidence of infection must act through the reproductive number. The key parameters determining the reproductive number and the relevance of risk behaviours depend upon the biology of the particular infection. The division between high transmission probability, short duration infections and low transmission probability, long duration infections is explored.

Entities:  

Mesh:

Year:  2002        PMID: 12083434      PMCID: PMC1765811          DOI: 10.1136/sti.78.suppl_1.i14

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  26 in total

1.  Polygyny, partnership concurrency, and HIV transmission in Sub-Saharan Africa.

Authors:  Georges Reniers; Rania Tfaily
Journal:  Demography       Date:  2012-08

2.  Frequency-dependent incidence in models of sexually transmitted diseases: portrayal of pair-based transmission and effects of illness on contact behaviour.

Authors:  James O Lloyd-Smith; Wayne M Getz; Hans V Westerhoff
Journal:  Proc Biol Sci       Date:  2004-03-22       Impact factor: 5.349

Review 3.  Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project.

Authors:  Elliot Marseille; Lalit Dandona; Joseph Saba; Coline McConnel; Brandi Rollins; Paul Gaist; Mattias Lundberg; Mead Over; Stefano Bertozzi; James G Kahn
Journal:  Health Serv Res       Date:  2004-12       Impact factor: 3.402

4.  Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-20       Impact factor: 4.254

Review 5.  Sexual risk behaviour and infection: epidemiological considerations.

Authors:  S O Aral
Journal:  Sex Transm Infect       Date:  2004-12       Impact factor: 3.519

6.  The interrelation of demographic and geospatial risk factors between four common sexually transmitted diseases.

Authors:  E F Monteiro; C J N Lacey; D Merrick
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

7.  Contact tracing strategies in heterogeneous populations.

Authors:  K T D Eames
Journal:  Epidemiol Infect       Date:  2006-07-19       Impact factor: 2.451

Review 8.  Behavioural data as an adjunct to HIV surveillance data.

Authors:  G P Garnett; J M Garcia-Calleja; T Rehle; S Gregson
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

9.  Concordance Between Laboratory Diagnosed Sexually Transmitted Infections and Self-Reported Measures of Risky Sex by Partner Type Among Rural Ugandan Outpatients.

Authors:  Susan M Kiene; Haruna Lule; Peter Hughes; Rhoda K Wanyenze
Journal:  AIDS Behav       Date:  2017-07

Review 10.  Criteria for detecting and understanding changes in the risk of HIV infection at a national level in generalised epidemics.

Authors:  G P Garnett; S Gregson; K A Stanecki
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.